Jun 2017 $3 M No. 9 $2 to $10 million 40
Chronix Biomedical Inc.: Raise no. 9, Jun 2017 × Investors in this round 40 investors had bought by the notice of Jul 18, 2017: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $8 M offered; $5 M still to sell
Smallest investment taken $2,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $250,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Ekkehard B Schuetz · Executive Officer Howard B Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David B MacKenzie · Director Michael B Jerstad · Director Paul B Freiman · Director Robert B Leppo · Director William B Boeger III · Director William B Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 18, 2017. Read the notice at the SEC .
equity SEC Dec 2016 $1 M No. 8 Under $2 million 25
Chronix Biomedical Inc.: Raise no. 8, Dec 2016 × Investors in this round 25 investors had bought by the notice of May 18, 2017: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken $2,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard B Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David B MacKenzie · Director Michael B Jerstad · Director Paul B Freiman · Director Robert B Leppo · Director William B Boeger III · Director William B Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed May 18, 2017. Read the notice at the SEC .
equity, options SEC Jun 2015 $5 M No. 7 $2 to $10 million 25
Chronix Biomedical Inc.: Raise no. 7, Jun 2015 × Investors in this round 25 investors had bought by the notice of Oct 31, 2016: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $5,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 31, 2016. Read the notice at the SEC .
equity SEC Jul 2013 $3 M No. 6 $2 to $10 million 26
Chronix Biomedical Inc.: Raise no. 6, Jul 2013 × Investors in this round 26 investors had bought by the notice of Apr 8, 2014: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $15 M offered; $11 M still to sell
Smallest investment taken $5,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 8, 2014. Read the notice at the SEC .
equity, options SEC Dec 2012 $3 M No. 5 $2 to $10 million 26
Chronix Biomedical Inc.: Raise no. 5, Dec 2012 × Investors in this round 26 investors had bought by the notice of Apr 9, 2014: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $15 M offered; $11 M still to sell
Smallest investment taken $5,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 9, 2014. Read the notice at the SEC .
equity, options SEC Aug 2012 $1 M No. 4 Under $2 million 7
Chronix Biomedical Inc.: Raise no. 4, Aug 2012 × Investors in this round 7 investors had bought by the notice of Oct 31, 2012: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken $1,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 31, 2012. Read the notice at the SEC .
equity, options SEC Jan 2011 $3 M No. 3 $2 to $10 million 11
Chronix Biomedical Inc.: Raise no. 3, Jan 2011 × Investors in this round 11 investors had bought by the notice of Mar 11, 2011: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken $1,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $610,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 11, 2011. Read the notice at the SEC .
equity, options SEC Mar 2010 $2 M No. 2 Under $2 million 14
Chronix Biomedical Inc.: Raise no. 2, Mar 2010 × Investors in this round 14 investors had bought by the notice of Sep 15, 2010: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken $5,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “All proceeds will be used for working capital of the company.”Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 15, 2010. Read the notice at the SEC .
equity SEC Sep 2009 $1 M No. 1 Under $2 million 14
Chronix Biomedical Inc.: Raise no. 1, Sep 2009 × Investors in this round 14 investors had bought by the notice of Nov 3, 2009: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $0 M still to sell
Smallest investment taken $5,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Howard Urnovitz · Executive Officer, Director John DiPietro · Executive Officer David MacKenzie · Director Michael Jerstad · Director Paul Freiman · Director Robert Leppo · Director William Boeger III · Director William Mitchell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “All proceeds will be used for working capital of the company.”Signed by John DiPietro, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 3, 2009. Read the notice at the SEC .
equity SEC